How Many Doses Per Vial of Glutathione? — Real Peptides

How Many Doses Per Vial of Glutathione?

Most glutathione vials don't come with a dose counter. Which creates confusion the moment you reconstitute the powder. A 200mg vial yields anywhere from 10 to 30 individual doses depending on your protocol, and miscalculating means you're either wasting peptide or underdosing. The difference between doing this correctly and guessing comes down to basic reconstitution math that most suppliers never explain.

Our team has worked with researchers navigating this exact calculation across hundreds of peptide protocols. The gap between confident dosing and perpetual uncertainty is a single formula. And understanding why concentration matters before you draw your first syringe.

How many doses are in a vial of glutathione?

A standard 200mg glutathione vial reconstituted with 2mL bacteriostatic water yields a concentration of 100mg/mL. At a typical research dose of 10mg per injection, this produces 20 doses per vial. Higher concentrations (200mg in 1mL) double the doses per vial to 40, while lower protocols (5mg per dose) extend yield proportionally. Vial lifespan post-reconstitution is 28 days refrigerated at 2–8°C.

The Featured Snippet gives you the standard scenario. But glutathione dosing isn't standardized. Research protocols range from 5mg daily microdoses to 50mg therapeutic doses three times weekly, and vial concentrations vary by supplier. A 200mg vial used at 5mg per dose yields 40 administrations. The same vial at 50mg per dose yields four. The vial size determines total peptide mass; your reconstitution volume determines concentration; your dose per injection determines how many times you draw from that vial. This article covers the reconstitution calculation that controls all three variables, the storage mistakes that destroy glutathione's sulfhydryl groups before you finish the vial, and what preparation errors waste peptide without triggering visible degradation.

Understanding Glutathione Vial Concentrations and Total Peptide Mass

Glutathione vials are sold by total peptide mass. Typically 200mg, 500mg, or 1000mg of lyophilized powder per vial. This number represents the bioactive compound weight before reconstitution, not the volume you'll inject. A 200mg vial contains exactly 200mg of glutathione tripeptide (gamma-L-glutamyl-L-cysteinyl-glycine) regardless of how much bacteriostatic water you add. The reconstitution volume determines concentration. Not potency.

Most suppliers provide glutathione as reduced glutathione (GSH), the active sulfhydryl form, rather than oxidized glutathione (GSSG). The reduced form is unstable in solution, which is why it ships as lyophilized powder and must be refrigerated immediately after mixing. A 200mg vial stored at −20°C before reconstitution remains stable for 12–24 months; the same vial reconstituted and left at room temperature loses measurable GSH content within 72 hours as the sulfhydryl groups oxidize.

Concentration math: if you add 2mL bacteriostatic water to a 200mg vial, the resulting solution is 200mg ÷ 2mL = 100mg/mL. Add 1mL instead, and concentration doubles to 200mg/mL. Higher concentrations reduce injection volume per dose but increase the risk of injection site irritation. Glutathione at concentrations above 150mg/mL can cause localized stinging in sensitive individuals. Most research protocols reconstitute to 50–100mg/mL as a balance between dose precision and injection comfort.

Our experience shows that researchers new to peptide reconstitution often confuse total vial mass with per-dose availability. A 1000mg vial sounds like it contains more doses than a 200mg vial. And it does. But only if your per-dose requirement remains constant. If your protocol calls for 20mg per administration, a 200mg vial yields 10 doses while a 1000mg vial yields 50. The cost per dose, not the vial size, determines value.

Calculating Doses Per Vial Based on Reconstitution Volume and Protocol

The formula that controls how many doses vial glutathione yields is:

Doses per vial = (Total peptide mass in mg) ÷ (Dose per injection in mg)

This calculation is independent of reconstitution volume. A 200mg vial dosed at 10mg per injection yields 20 doses whether you reconstitute with 1mL, 2mL, or 5mL of bacteriostatic water. What changes is the injection volume you draw per dose.

To determine injection volume per dose, use:

Injection volume (mL) = (Dose in mg) ÷ (Concentration in mg/mL)

Example: You have a 500mg vial reconstituted with 5mL bacteriostatic water. Concentration = 500mg ÷ 5mL = 100mg/mL. Your protocol calls for 15mg per dose. Injection volume = 15mg ÷ 100mg/mL = 0.15mL per dose. Total doses = 500mg ÷ 15mg = 33.3 doses (round down to 33 full doses).

Most insulin syringes used for subcutaneous peptide injection are graduated in 0.01mL (1-unit) increments on a 1mL barrel. Drawing 0.15mL is straightforward. 15 units on the syringe. Doses requiring volumes smaller than 0.05mL (5 units) increase measurement error significantly. If your calculation yields injection volumes below 0.05mL, reconstitute with less bacteriostatic water to increase concentration.

Research protocols for glutathione vary widely by intended endpoint. Antioxidant support studies often use 5–10mg daily doses. Skin brightening and detoxification protocols escalate to 20–50mg three times weekly. Athletic recovery research sometimes employs 100mg post-exercise doses. A single 200mg vial serves 40 days at 5mg daily, 10 days at 20mg daily, or four administrations at 50mg per dose. The vial doesn't determine your protocol. Your protocol determines which vial size to order.

Storage, Stability, and the 28-Day Post-Reconstitution Window

Glutathione's reduced sulfhydryl group is chemically fragile. Once reconstituted with bacteriostatic water, the peptide remains stable for 28 days when refrigerated at 2–8°C in the original sterile vial. This timeline is determined by oxidative degradation, not bacterial contamination. The benzyl alcohol in bacteriostatic water prevents microbial growth for months, but it does nothing to prevent GSH from converting to GSSG.

Temperature excursions above 8°C accelerate oxidation exponentially. A vial left at room temperature (20–25°C) for 24 hours loses approximately 15–20% of measurable reduced glutathione content. The same vial left in a car on a warm day (30–35°C) for six hours can lose 40% or more. This degradation is irreversible. You cannot restore GSH by refrigerating oxidized GSSG. The peptide appears unchanged visually, but potency drops below therapeutic thresholds.

Our team has found that the reconstitution step itself introduces the highest contamination risk. If you inject air into the vial while drawing solution, the resulting positive pressure forces droplets back through the needle on subsequent draws, carrying contaminants into the vial. Proper technique: pierce the stopper with the needle, invert the vial, draw solution without injecting air, and withdraw the needle immediately. Wiping the stopper with an alcohol prep pad before each puncture reduces contamination further.

Freezing reconstituted glutathione extends shelf life to 90 days, but introduces a separate risk. Ice crystal formation during the freeze-thaw cycle can denature protein structure in some peptide formulations. Glutathione is a tripeptide, not a full protein, so freeze-thaw damage is less pronounced than with larger molecules like BPC-157 or thymosin beta-4. If you choose to freeze reconstituted glutathione, use single-use aliquots in sterile cryovials rather than freezing and thawing the entire vial repeatedly.

Light exposure degrades glutathione through photochemical oxidation. Store reconstituted vials in amber glass or wrap clear vials in aluminum foil. UV exposure from standard laboratory lighting for 48 hours can reduce GSH content by 10–15% even when refrigerated.

How Many Doses Per Vial of Glutathione: Concentration Comparison

200mg

2mL

100mg/mL

10mg

0.10mL

20 doses

Standard protocol. Ideal balance between dose precision and injection comfort for daily antioxidant research

1mL

200mg/mL

0.05mL

Higher concentration reduces injection volume but may cause localized irritation in sensitive subjects

500mg

5mL

25mg

0.25mL

Therapeutic-range dosing for detoxification or skin research. Manageable injection volume

1000mg

10mL

50mg

0.50mL

High-dose protocols. Larger injection volumes may require splitting into two sites

5mg

40 doses

Microdosing protocol. Extends vial lifespan but challenges measurement precision with standard syringes

The table shows that total doses per vial depend entirely on your per-injection dose, not vial size or concentration. A 200mg vial yields 20 doses at 10mg per injection whether you reconstitute with 1mL or 2mL. Concentration changes injection volume, not dose count.

Key Takeaways

A 200mg glutathione vial reconstituted with 2mL bacteriostatic water yields 100mg/mL concentration, producing 20 doses at 10mg per injection.

Total doses per vial = (vial peptide mass in mg) ÷ (dose per injection in mg). This calculation is independent of reconstitution volume.

Reconstituted glutathione remains stable for 28 days refrigerated at 2–8°C due to oxidative degradation of the sulfhydryl group, not bacterial contamination.

Temperature excursions above 8°C cause irreversible loss of reduced glutathione (GSH) to oxidized glutathione (GSSG), which cannot be reversed by refrigeration.

Injection volume per dose = (dose in mg) ÷ (concentration in mg/mL). Doses requiring less than 0.05mL increase measurement error with standard insulin syringes.

Higher concentrations (150–200mg/mL) reduce injection volume but increase the risk of localized stinging at the injection site.

What If: Glutathione Dosing and Storage Scenarios

What If I Miscalculated My Reconstitution Volume and the Concentration Is Too High?

Add more bacteriostatic water to the vial to dilute the solution. Calculate the total volume already in the vial (original reconstitution volume), determine your target concentration, and add the difference. Example: you added 1mL to a 200mg vial (200mg/mL) but wanted 100mg/mL. Add another 1mL to reach 2mL total volume, halving the concentration. Glutathione stability is not affected by dilution as long as you use sterile bacteriostatic water and maintain refrigeration. Do not exceed 10mL total volume in a standard 10mL sterile vial to prevent overfilling.

What If I Left My Reconstituted Glutathione Out of the Fridge Overnight?

Discard the vial. A temperature excursion above 8°C for 8–12 hours causes oxidative degradation that reduces bioactive GSH content by 20–40%, and the remaining peptide appears unchanged visually. Glutathione does not develop cloudiness or discoloration when it oxidizes. The solution looks identical whether it contains 100% GSH or 60% GSSG. Using partially degraded glutathione wastes the dose without delivering therapeutic benefit. The financial cost of replacing the vial is lower than the research cost of invalid data from underdosed protocols.

What If My Protocol Requires 3mg Per Dose and My Syringe Graduations Are Too Large?

Reconstitute to a lower concentration so the required injection volume is easier to measure. A 200mg vial reconstituted with 10mL yields 20mg/mL concentration. At 3mg per dose, injection volume = 3mg ÷ 20mg/mL = 0.15mL (15 units on a standard insulin syringe). Alternatively, switch to a 0.5mL insulin syringe with finer graduations (0.5-unit increments) for improved precision. Doses below 0.05mL introduce ±10–15% measurement variability with 1mL syringes. Reconstitution volume adjustment is more reliable than attempting ultra-precise draws.

The Unfiltered Truth About Glutathione Vial Dosing

Here's the honest answer: most researchers waste 20–30% of every glutathione vial not because they dose incorrectly, but because they don't calculate shelf life before reconstituting the entire vial. A 1000mg vial reconstituted at once for a 10mg daily protocol yields 100 doses. But expires in 28 days. You'll discard 72 doses. The financially and scientifically rational approach is to reconstitute smaller aliquots as needed or order appropriately sized vials matched to your protocol duration. Suppliers rarely mention this because larger vials carry higher margins.

The second issue rarely discussed: bacteriostatic water is not interchangeable with sterile water for injection. Bacteriostatic water contains 0.9% benzyl alcohol as a preservative, which prevents bacterial growth in multi-dose vials. Sterile water lacks this preservative and must be used immediately after opening. It cannot support a 28-day multi-dose protocol. Using sterile water for a vial you plan to draw from 20 times over four weeks introduces contamination risk that benzyl alcohol would otherwise eliminate. Every reputable peptide protocol specifies bacteriostatic water for this exact reason.

Glutathione is one of the most chemically unstable peptides in therapeutic use. Its tripeptide structure and free sulfhydryl group make it vulnerable to oxidation, light exposure, heat, and pH shifts that leave other peptides unaffected. If your storage and reconstitution technique works flawlessly for BPC-157 or semaglutide, it may still fail for glutathione. The vial yields exactly as many doses as the math predicts. But only if you protect those doses from the environmental factors that turn reduced glutathione into an expensive placebo.

Dosing confidence comes from understanding the variables you control. Vial size, reconstitution volume, injection dose, and storage conditions. The variables you don't control. Peptide purity, lyophilization quality, supplier cold chain management. Require sourcing from manufacturers with documented quality assurance. Real Peptides produces glutathione through small-batch synthesis with third-party purity verification, ensuring that a 200mg vial contains 200mg of bioactive GSH before it leaves the facility. That consistency eliminates one variable from the reconstitution equation.

Calculating doses per vial of glutathione is not complex. It's a two-step formula most high school students could execute. The complexity is in recognizing that the calculation assumes the peptide remains chemically stable from reconstitution to final dose, which requires refrigeration discipline, sterile technique, and appropriate vial sizing for your protocol duration. Get those three factors right, and a 200mg vial yields exactly 20 doses at 10mg per injection. Get them wrong, and the same vial yields 12 usable doses and eight wasted ones.

Frequently Asked Questions

Divide the total peptide mass in the vial (in mg) by your dose per injection (in mg). A 200mg vial dosed at 10mg per injection yields 20 doses. This calculation is independent of how much bacteriostatic water you use for reconstitution — reconstitution volume affects injection volume per dose, not total doses available.

No. Reconstituted glutathione degrades through oxidative conversion of reduced glutathione (GSH) to oxidized glutathione (GSSG) even when refrigerated at 2–8°C. The 28-day shelf life reflects this chemical instability, not bacterial contamination. Bacteriostatic water prevents microbial growth for months, but it does not prevent oxidation. Using a vial beyond 28 days post-reconstitution delivers progressively lower bioactive GSH content.

Most research protocols reconstitute to 50–100mg/mL as a balance between dose precision and injection comfort. Concentrations above 150mg/mL can cause localized stinging at the injection site due to osmotic pressure. If your protocol requires very small doses (under 5mg), reconstitute to a lower concentration (20–50mg/mL) so the injection volume is easier to measure accurately with standard insulin syringes.

Larger vials reduce cost per milligram of peptide but only deliver savings if you use the entire vial within 28 days post-reconstitution. A 1000mg vial is more cost-effective than five 200mg vials on a per-dose basis — but if your protocol only requires 200mg over 28 days, you’ll discard 800mg of unusable peptide. Calculate your total peptide requirement for a 28-day cycle, then order the smallest vial size that meets or slightly exceeds that amount.

Injecting air creates positive pressure inside the vial, which forces liquid back through the needle when you withdraw it — potentially introducing contaminants from the needle exterior or stopper surface into the vial. Proper technique is to pierce the stopper, invert the vial, draw the solution without injecting air, and withdraw immediately. If you’ve already introduced air, wipe the stopper with an alcohol prep pad before every subsequent draw to minimize contamination risk.

Yes. Reduced glutathione (GSH) is the bioactive form with a free sulfhydryl group that provides antioxidant activity. Oxidized glutathione (GSSG) is the inactive disulfide form. Most research-grade glutathione vials contain GSH unless explicitly labeled otherwise. Once reconstituted, GSH gradually oxidizes to GSSG over time, which is why refrigerated storage and the 28-day shelf life are critical.

Yes, if done under sterile conditions. Reconstitute the vial, then transfer measured aliquots into sterile cryovials using aseptic technique in a clean environment. Freeze aliquots at −20°C, which extends shelf life to approximately 90 days. Thaw one aliquot at a time in the refrigerator when needed. Do not refreeze thawed aliquots — freeze-thaw cycles degrade peptide structure.

Glutathione does not develop visible cloudiness, precipitation, or discoloration when it oxidizes from GSH to GSSG. The solution appears identical whether it is 100% bioactive or 50% degraded. This is why temperature control is non-negotiable — you cannot visually assess potency loss. If a reconstituted vial has been stored above 8°C for more than a few hours, assume significant degradation has occurred and discard it.

Bacteriostatic water contains 0.9% benzyl alcohol, which prevents bacterial growth in multi-dose vials and allows safe use over 28 days. Sterile water for injection lacks this preservative and must be used immediately after opening — it is not suitable for vials you will draw from multiple times. All multi-dose peptide protocols require bacteriostatic water to prevent contamination across repeated needle punctures.

If you experience localized stinging, burning, or prolonged redness at the injection site, the concentration may exceed tissue tolerance. Concentrations above 150mg/mL increase osmotic pressure, which irritates subcutaneous tissue. Reconstitute with additional bacteriostatic water to dilute the solution — this does not affect total doses available, only the volume you inject per dose. Most researchers find 100mg/mL or lower eliminates injection site discomfort.